Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01743625 · ClinicalTrials.gov registry record · Phase 3

Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain

A Phase 3 study, sponsored by Mallinckrodt.

Completed
Registry status
Phase 3
Development phase
406
Enrollment target

NCT01743625: Completed Phase 3 study, sponsored by Mallinckrodt.

NCT01743625 is a Phase 3 study that has completed, run by Mallinckrodt. The registered enrollment target is 406 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01743625, a Phase 3 study, has completed, sponsored by Mallinckrodt.

COMPLETED
Registry status
Phase 3
Development phase
406 participants
Enrollment target

Study Summary

The purpose of this study is to show the effectiveness of COV155 compared to placebo in subjects with acute moderate to severe pain following bunionectomy surgery.

Primary Outcome

48 hour Summed pain intensity difference

Interventions

  • DRUG placebo
  • DRUG COV155

Trial Details

FieldValue
Enrollment Target 406 participants
Start Date 2012-11
Est. Completion 2013-07
Phase Phase 3
Mallinckrodt

69 total trials

What the finished NCT01743625 record still lists

NCT01743625 is an interventional study that assigns participants to a tested intervention. The registered 406 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% lower).

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT01743625 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01743625 about?

NCT01743625 is a clinical study titled "Safety and Efficacy Study of COV155 for Post-operative Bunionectomy Pain". The purpose of this study is to show the effectiveness of COV155 compared to placebo in subjects with acute moderate to severe pain following bunionectomy surgery.

What is the current status of trial NCT01743625?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 406 participants. The study started on 2012-11. Estimated completion is 2013-07.

What interventions are being tested in trial NCT01743625?

The interventions under investigation include: placebo (DRUG), COV155 (DRUG).

Who is sponsoring clinical trial NCT01743625?

This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01743625's enrollment target sits among peer trials

406 913th of 2000 higher than 1,087 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06223360 · 406 participants · Phase 2

    A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

  • NCT06411769 · 406 participants · NA

    Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas

  • NCT06585787 · 406 participants · Phase 3

    A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  • NCT06735534 · 407 participants · NA

    Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01743625, the US trial registry maintained by the National Library of Medicine. NCT01743625 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.